{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:43:22Z","timestamp":1792543402816,"version":"4.5.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02685-4","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T06:02:06Z","timestamp":1691042526000},"page":"2737-2739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of diagnostic delay on patient perspectives in pyoderma gangrenosum: an online support group-based survey study"],"prefix":"10.1007","volume":"315","author":[{"given":"Linh Tang","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Kody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Rios-Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"issue":"10","key":"2685_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/ddg.12822","volume":"13","author":"U Beiteke","year":"2015","unstructured":"Beiteke U, Bigge S, Reichenberger C, Gralow I (2015) Pain and pain management in dermatology. J Dtsch Dermatol Ges 13(10):967\u2013987. https:\/\/doi.org\/10.1111\/ddg.12822","journal-title":"J Dtsch Dermatol Ges"},{"key":"2685_CR2","doi-asserted-by":"crossref","unstructured":"Erickson KM, Kody S, Ortega-Loayza AG (2023) Pain as a patient reported outcome measure in pyoderma gangrenosum: defining clinical significance. JAMA Dermatol, Accepted for publication","DOI":"10.1001\/jamadermatol.2023.3115"},{"key":"2685_CR3","doi-asserted-by":"publisher","unstructured":"Hobbs MM, Byler R, Latour E, Bonomo L, Hennessy K, Cruz-Diaz C N, Shinohara MM, Seminario-Vidal L, Shinkai K, Ortega-Loayza AG (2021) Treatment of pyoderma gangrenosum: a multicenter survey-based study assessing satisfaction and quality of life. Dermatol Ther 34(2):e14736. https:\/\/doi.org\/10.1111\/dth.14736","DOI":"10.1111\/dth.14736"},{"key":"2685_CR4","doi-asserted-by":"publisher","unstructured":"Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston G A, Williams HC, UK Dermatology Clinical Trials Network\u2019s STOP GAP Team (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ (Clinical research Ed.), 350: h2958. https:\/\/doi.org\/10.1136\/bmj.h2958","DOI":"10.1136\/bmj.h2958"},{"issue":"5","key":"2685_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jaad.2022.02.008","volume":"87","author":"AM Reese","year":"2022","unstructured":"Reese AM, Gupta AS, Latour E, Loyo M, Kaffenberger B, Creadore A, Mostaghimi A, Seminario-Vidal L, Rick J, Ortega-Loayza AG (2022) Clinical characteristics and misdiagnosis of pyoderma gangrenosum of the head and neck: a retrospective study. J Am Acad Dermatol 87(5):1130\u20131133. https:\/\/doi.org\/10.1016\/j.jaad.2022.02.008","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:05:47Z","timestamp":1695283547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":5,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2685"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02685-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ortega-Loayza is President-elect of the Pacific Dermatology Association and serves as an associate editor for <i>Dermatology<\/i>. Additionally, he is a consultant for Genentech and Guidepoint and an advisor to Bristol Meyer Squibb, Boehringer Ingelheim and Janssen. Dr. Ortega has received research grants from Lilly, Janssen and Pfizer. The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Oregon Health & Science University\u2019s Institutional Review Board (IRB #21834).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}]}}